Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Gaspersic, N. et al.

Gaspersic, Ambrozic, Bozic, Majhenc, Svetina, Rozman,

Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-{beta}2-glycoprotein I and anti-annexin A5 antibodies.

OBJECTIVES: Anti-phospholipid antibodies have been recognized to play a role in vascular thrombosis and pregnancy morbidity. They were first thought to be directed to phospholipids, but it is now known that the majority of pathogenic antibodies recognizes epitopes on phospholipid-binding plasma proteins such as beta(2)-glycoprotein I (beta(2)GPI) or possibly also annexin A5 (ANXA5). The mechanism of their prothrombotic action is still not completely understood. The aim of the present study was to observe the effect of antibodies against ANXA5 (aANXA5) and antibodies against beta(2)GPI (abeta(2)GPI) on the binding of ANXA5 to the negatively charged phospholipid membrane. METHODS: Giant phospholipid vesicles (GPVs) were used as a simple model of the membrane surface. GPVs composed of phosphatidylserine and phosphatidylcholine were produced in an aqueous medium. A single GPV was transferred to the solution containing ANXA5 conjugated with Alexa Fluor 488 (FANXA5) and (i) aANXA5 or abeta(2)GPI and (ii) different concentrations of abeta(2)GPI together with beta(2)GPI. The emission of the fluorescent light from the GPV surface, as the result of FANXA5 binding, was measured. RESULTS: beta(2)GPI together with abeta(2)GPI reduced the binding of FANXA5 to GPVs. On the contrary, aANXA5 enhanced the binding of ANXA5 to the GPV surface. CONCLUSIONS: Our results point to the competition between FANXA5 and complexes of beta(2)GPI-abeta(2)GPI for the same binding sites and therefore support the hypothesis of the disruption of the ANXA5 protective shield on procoagulant phospholipid surface. The influence of increased cell surface ANXA5 concentration in the presence of aANXA5 on coagulation needs to be further studied.[1]

References

Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-{beta}2-glycoprotein I and anti-annexin A5 antibodies. Gaspersic, N., Ambrozic, A., Bozic, B., Majhenc, J., Svetina, S., Rozman, B. Rheumatology (Oxford, England) (2007) [Pubmed]

Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.